Urinary Incontinence News and Research

RSS
Urinary incontinence (UI), or the unintentional loss of urine, is a problem for more than 13 million Americans—85 percent of them women. Although about half of the elderly have episodes of incontinence, bladder problems are not a natural consequence of aging, and they are not exclusively a problem of the elderly.

Incontinence has several causes. Women are most likely to develop incontinence either during pregnancy and childbirth, or after the hormonal changes of menopause, because of weakened pelvic muscles. Older men can become incontinent as the result of prostate surgery. Pelvic trauma, spinal cord damage, caffeine, or medications including cold or over-the-counter diet tablets also can cause episodes of incontinence.

But even though urinary incontinence can be improved in 8 out of 10 cases, fewer than half of those with bladder problems ever discuss the condition with their health care professional. The condition often goes untreated.
Uroplasty announces newly-issued patent for Urgent PC Neuromodulation System

Uroplasty announces newly-issued patent for Urgent PC Neuromodulation System

Positive preliminary results from MediciNova's Phase Ib clinical trial of MN-221 for COPD

Positive preliminary results from MediciNova's Phase Ib clinical trial of MN-221 for COPD

Adult female stress urinary incontinence: Uroplasty launches new endoscopic injection needle

Adult female stress urinary incontinence: Uroplasty launches new endoscopic injection needle

Type of specialist that men with prostate cancer see can influence form of therapy they ultimately receive

Type of specialist that men with prostate cancer see can influence form of therapy they ultimately receive

Likvor receives first order for Likvor CELDA system from Aalborg Hospital, North Denmark Region

Likvor receives first order for Likvor CELDA system from Aalborg Hospital, North Denmark Region

Urinary catheterization of men and women: NAFC releases new consumer educational resource

Urinary catheterization of men and women: NAFC releases new consumer educational resource

Macroplastique effective for stress urinary incontinence in women

Macroplastique effective for stress urinary incontinence in women

Antares Pharma completes enrollment in Phase 3 clinical trial of Anturol for OAB

Antares Pharma completes enrollment in Phase 3 clinical trial of Anturol for OAB

Uroplasty's Urgent PC Neuromodulation System SUmiT Trial demonstrates effectiveness of PTNS

Uroplasty's Urgent PC Neuromodulation System SUmiT Trial demonstrates effectiveness of PTNS

Study: Several types of treatment can provide relief for pelvic floor disorders

Study: Several types of treatment can provide relief for pelvic floor disorders

Article features pelvic health problems, risk factors and treatment options for women

Article features pelvic health problems, risk factors and treatment options for women

Big Ow awareness campaign

Big Ow awareness campaign

New U.S. patent broadens Cytori Therapeutics' portfolio covering adipose-derived cell therapies

New U.S. patent broadens Cytori Therapeutics' portfolio covering adipose-derived cell therapies

Inadequate saliva and fluoride can contribute to tooth decay

Inadequate saliva and fluoride can contribute to tooth decay

LinkMed’s portfolio company Likvor receives new order for Likvor CELDA

LinkMed’s portfolio company Likvor receives new order for Likvor CELDA

AUA updates clinical practice guideline on female stress urinary incontinence

AUA updates clinical practice guideline on female stress urinary incontinence

Despite economic downturn, Russia still represents a promising healthcare market

Despite economic downturn, Russia still represents a promising healthcare market

Cryo-Cell International continues to expand R&D initiatives to accelerate therapeutic benefits of stem cells

Cryo-Cell International continues to expand R&D initiatives to accelerate therapeutic benefits of stem cells

Uppsala University Hospital orders CELDA from Likvor for diagnosing NPH

Uppsala University Hospital orders CELDA from Likvor for diagnosing NPH

Uroplasty to publish 12-month results of its OrBIT Urgent PC Neuromodulation System trial

Uroplasty to publish 12-month results of its OrBIT Urgent PC Neuromodulation System trial